Skip to content

Opening book details…

About this Medicine article

Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na+-dependent taurocholate cotransporting polypeptide activity by Wang, Xue-jun; Hu, Wei; Zhang, Ting-yu; Mao, Ying-ying; Liu, Nan-nan; Wang, Sheng-qi is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Wang, Xue-jun; Hu, Wei; Zhang, Ting-yu; Mao, Ying-ying; Liu, Nan-nan; Wang, Sheng-qi
Publisher
Elsevier Science; Elsevier ; Elsevier BV (ISSN 0166-3542)
Published
2015
Language
EN
Field
Medicine (Health Sciences)

More by Wang, Xue-jun; Hu, Wei; Zhang, Ting-yu; Mao, Ying-ying; Liu, Nan-nan; Wang, Sheng-qi

Browse all works by Wang, Xue-jun; Hu, Wei; Zhang, Ting-yu; Mao, Ying-ying; Liu, Nan-nan; Wang, Sheng-qi